vs
Side-by-side financial comparison of Allegiant Travel CO (ALGT) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $595.5M, roughly 1.0× Allegiant Travel CO). Royalty Pharma plc runs the higher net margin — 34.4% vs 5.4%, a 29.1% gap on every dollar of revenue. On growth, Allegiant Travel CO posted the faster year-over-year revenue change (7.6% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 1.3%).
Allegiant Air, styled as allegiant, is an American low-cost airline headquartered in Las Vegas, Nevada. The airline focuses on serving leisure traffic from small and medium-sized cities which it considers to be underserved, using an ultra low-cost business model with minimal inclusions in fares and a greater number of add-on fees.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
ALGT vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $595.5M | $622.0M |
| Net Profit | $31.9M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 11.2% | 62.4% |
| Net Margin | 5.4% | 34.4% |
| Revenue YoY | 7.6% | 4.8% |
| Net Profit YoY | 114.8% | 2.9% |
| EPS (diluted) | $1.82 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $595.5M | $622.0M | ||
| Q3 25 | $494.1M | $609.3M | ||
| Q2 25 | $617.9M | $578.7M | ||
| Q1 25 | $616.8M | $568.2M | ||
| Q4 24 | $553.6M | $593.6M | ||
| Q3 24 | $489.0M | $564.7M | ||
| Q2 24 | $594.5M | $537.3M | ||
| Q1 24 | $579.9M | $568.0M |
| Q4 25 | $31.9M | $214.2M | ||
| Q3 25 | $-43.6M | $288.2M | ||
| Q2 25 | $-65.2M | $30.2M | ||
| Q1 25 | $32.1M | $238.3M | ||
| Q4 24 | $-216.2M | $208.2M | ||
| Q3 24 | $-36.8M | $544.0M | ||
| Q2 24 | $13.7M | $102.0M | ||
| Q1 24 | $-919.0K | $4.8M |
| Q4 25 | 11.2% | 62.4% | ||
| Q3 25 | -5.5% | 70.1% | ||
| Q2 25 | -10.9% | 36.3% | ||
| Q1 25 | 10.5% | 94.0% | ||
| Q4 24 | -47.7% | 60.9% | ||
| Q3 24 | -5.4% | — | ||
| Q2 24 | 5.9% | 50.2% | ||
| Q1 24 | 2.7% | -13.0% |
| Q4 25 | 5.4% | 34.4% | ||
| Q3 25 | -8.8% | 47.3% | ||
| Q2 25 | -10.5% | 5.2% | ||
| Q1 25 | 5.2% | 41.9% | ||
| Q4 24 | -39.1% | 35.1% | ||
| Q3 24 | -7.5% | 96.3% | ||
| Q2 24 | 2.3% | 19.0% | ||
| Q1 24 | -0.2% | 0.8% |
| Q4 25 | $1.82 | $0.49 | ||
| Q3 25 | $-2.41 | $0.67 | ||
| Q2 25 | $-3.62 | $0.07 | ||
| Q1 25 | $1.73 | $0.55 | ||
| Q4 24 | $-12.12 | $0.46 | ||
| Q3 24 | $-2.05 | $1.21 | ||
| Q2 24 | $0.75 | $0.23 | ||
| Q1 24 | $-0.07 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $805.7M | $618.7M |
| Total DebtLower is stronger | $1.7B | $9.0B |
| Stockholders' EquityBook value | $1.1B | $9.7B |
| Total Assets | $4.2B | $19.6B |
| Debt / EquityLower = less leverage | 1.60× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $805.7M | $618.7M | ||
| Q3 25 | $956.7M | $938.9M | ||
| Q2 25 | $842.8M | $631.9M | ||
| Q1 25 | $878.6M | $1.1B | ||
| Q4 24 | $781.1M | $929.0M | ||
| Q3 24 | $759.3M | $950.1M | ||
| Q2 24 | $791.9M | $1.8B | ||
| Q1 24 | $809.9M | $843.0M |
| Q4 25 | $1.7B | $9.0B | ||
| Q3 25 | $1.8B | $8.9B | ||
| Q2 25 | $1.8B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.6B | $7.6B | ||
| Q3 24 | $1.8B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | $1.8B | $6.1B |
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.0B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.3B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
| Q4 25 | $4.2B | $19.6B | ||
| Q3 25 | $4.4B | $19.3B | ||
| Q2 25 | $4.4B | $18.3B | ||
| Q1 25 | $4.5B | $17.6B | ||
| Q4 24 | $4.4B | $18.2B | ||
| Q3 24 | $4.8B | $18.0B | ||
| Q2 24 | $4.9B | $17.7B | ||
| Q1 24 | $4.9B | $16.1B |
| Q4 25 | 1.60× | 0.92× | ||
| Q3 25 | 1.76× | 0.93× | ||
| Q2 25 | 1.68× | 0.84× | ||
| Q1 25 | 1.57× | 0.78× | ||
| Q4 24 | 1.48× | 0.74× | ||
| Q3 24 | 1.36× | 0.74× | ||
| Q2 24 | 1.30× | 0.78× | ||
| Q1 24 | 1.35× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $112.2M | $827.1M |
| Free Cash FlowOCF − Capex | $90.4M | — |
| FCF MarginFCF / Revenue | 15.2% | — |
| Capex IntensityCapex / Revenue | 3.7% | — |
| Cash ConversionOCF / Net Profit | 3.51× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.2M | $827.1M | ||
| Q3 25 | $-6.1M | $702.6M | ||
| Q2 25 | $92.2M | $364.0M | ||
| Q1 25 | $191.4M | $596.1M | ||
| Q4 24 | $84.4M | $742.5M | ||
| Q3 24 | $17.3M | $703.6M | ||
| Q2 24 | $68.9M | $658.2M | ||
| Q1 24 | $167.8M | $664.6M |
| Q4 25 | $90.4M | — | ||
| Q3 25 | $-121.7M | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $116.9M | — | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $-28.7M | — | ||
| Q2 24 | $7.0M | — | ||
| Q1 24 | $35.9M | — |
| Q4 25 | 15.2% | — | ||
| Q3 25 | -24.6% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | 19.0% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | -5.9% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 6.2% | — |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 10.4% | — | ||
| Q1 24 | 22.7% | — |
| Q4 25 | 3.51× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 5.96× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 5.03× | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALGT
| Airrelatedrevenue | $307.1M | 52% |
| Scheduled Service Revenue | $267.1M | 45% |
| Cobrand Revenue | $21.3M | 4% |
| Other | $1.0K | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
